Synonyms: AR-R15896AR | ARL 15896 | AZD-6765 | AZD6765
Compound class:
Synthetic organic
Comment: Lanicemine (AZD 6765) was originally developed as a neuroprotective agent, but was repurposed as an antidepressant with potential for the management of severe and treatment-resistant depression [3]. However, the compound failed to meet study endpoints, so development was halted. The compound is discussed in the AZ 2014 review paper [1].
The structure represented here shows stereochemistry identical to the INN record wheras PubChem CID 3038485 represents the non-chiral molecule. |
|
Bioactivity Comments |
Lanicemine (ARL 15896) is a non-selective NMDA channel blocker, with IC50 values ranging from 12.6-33.9nM at various human NMDA receptors (co-expression of different subunit combinations) expressed in X. laevis oocytes [2]. |